HQLNYSEFiscal year ends September 30
abrdn Life Sciences Investors
$17.03+0.25 (+1.49%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About abrdn Life Sciences Investors
abrdn Life Sciences Investors is listed on NYSE under the ticker HQL. It is incorporated in Massachusetts and its fiscal year ends on September 30.
Company profile
Company
- Legal name
- abrdn Life Sciences Investors
- Headquarters
- Philadelphia, PA
- Address
- 1900 Market Street, Suite 200 19103
- Phone
- (617) 772-8515
- Incorporated in
- Massachusetts
- Fiscal year ends
- September 30
Stock & identifiers
- Ticker
- HQL
- Exchange
- NYSE
- IPO date
- May 1, 1992
- SEC CIK
- 884121
- CUSIP
- 87911K100
- ISIN
- US87911K1007
- LEI
- 5493007BYZPSOVVS0M04
- EIN
- 04-3147016
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Heather Carter Reilly | Vice President | – |
| Michael Taggart | Vice President | – |
| Robert W. Hepp | Vice President | – |
| Michael Marsico | Vice President | – |
| Andrew Wonil Kim | Vice President | – |
| Heather Rose Hasson | Vice President | – |
| Katie Lynn Gebauer | Vice President | – |
| Ashton Wilson | Vice President | – |
| Kolotioloma Silue | Vice President | – |
| Chris LaVictoire Mahai | Director | 527 |
| Christian Pittard | Director | 7,923 |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 5, 2023 | Name change | Name changed from TEKLA LIFE SCIENCES INVESTORS to abrdn Life Sciences Investors |
| Sep 12, 2023 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Sep 18, 2014 | Name change | Name changed from H&Q LIFE SCIENCES INVESTORS to TEKLA LIFE SCIENCES INVESTORS |